Sasol is a global chemicals and energy company. We harness our knowledge and expertise to integrate sophisticated technologies and processes into world-scale operating facilities. We safely and sustainably source, produce and market a range of high-quality products, creating value for stakeholders.
Sasol comprises three distinct market-focused businesses, namely: Chemicals, Energy and Sasol ecoFT. Our more focused portfolio is underpinned by a transition to a lower-carbon future and our 70-year track record demonstrates we have the capabilities and competencies to deliver sustainable value in these three core businesses.
Advancing chemical and energy solutions that contribute to a thriving planet, society and enterprise.
Sasol's investors consist of both equity investors (those invested in the Sasol ordinary shares or the ADRs) and lenders/debt investors (banks and institutional investors lending to Sasol or investing in its issues of debt instruments such as local bonds, offshore bonds, commercial paper issues, project finance, loans and other credit facilities and convertible instruments).
Supply Chain is the custodian of all external spend for the Sasol Group. It is responsible for managing supply and demand so as to ensure cost-efficiency and maximise return on spend, while at the same time ensuring effective logistics of a range of deliverables.
Explore existing opportunities to energise your career to the next level. Whether you are seeking a Learnership or you are Student or Graduate or Experienced Hire. Find out how you can add value to the Sasol Team.
Access media releases and view latest social media updates
HAMBURG, Germany, March 31, 2022 – Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL) and Holiferm Limited announced today a partnership to jointly develop new biosurfactants and enable the broad commercialisation of sophorolipids.
Sasol Chemicals has agreed to purchase the majority of sophorolipids produced at a new Holiferm manufacturing facility in the United Kingdom, which is under construction and scheduled to begin operations in early 2023. Sasol Chemicals will also fund Holiferm research and development to accelerate innovation initiatives to help meet growing demand for sustainable solutions in primary surfactants.
Biosurfactants, which are produced using natural materials, are key ingredients in detergents, cleaning products and personal care products. Sophorolipids are biosurfactants made through fermentation, using yeast to convert vegetable oils and glucose into themi final product. The Holiferm process offers an extensive reduction in carbon footprint comparative to conventional surfactants.
“We are increasingly using bio-based raw materials to make our products, as we work with our customers to develop solutions that in turn make their products more sustainable,” said Silke Hoppe, Vice President of Essential Care Chemicals for Sasol Chemicals. “The Holiferm expertise in the area of fermentation technology and production is a perfect fit with Sasol’s position as a global leader in the supply of surfactants and surfactant intermediates into the Fabric and Home Care, Personal Care as well as Industrial and Institutional Cleaning markets.”
Essential Care Chemicals is a global customer-focused business division dedicated to innovating sustainable solutions for people and the planet. Using in-depth knowledge of different markets, applications and products, it creates advanced high-performance solutions in the following core markets: Fabric Home Care, Industrial and Institutional Cleaning, Personal Care, Health and Wellness, and Technical Markets including Energy.
“We at Holiferm truly believe in the future of biosurfactants and fermentation technologies to reduce the dependence on fossil-based chemicals,” said Richard Lock Managing Director of Holiferm. “The drive, passion and commitment Sasol Chemicals are showing with Holiferm Limited is a perfect fit, for both companies and the planet as a whole.”
Financial terms of the agreements between Sasol Chemicals and Holiferm Limited were not disclosed.